METHOTREXATE TEVA 2.5 % (500 mg/20 ml), solution for injection bottle, 20 ml
Brand page: Novatrex, Imeth (methotrexate) — all forms and strengths in France
Active ingredients: Methotrexate
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for injectionbottle, 20 mlintraartérielle;intramusculaire;intraveineuse;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- METHOTREXATE TEVA 2,5 POUR CENT (500 mg/20 mL), solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intraartérielle;intramusculaire;intraveineuse;sous-cutanée
- Presentation description
- 1 flacon(s) en verre de 20 mL
- Marketing authorisation holder
- TEVA SANTE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Jan 1998
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65288721CIP75601968CIP133400956019687Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MÉTHOTREXATEsolution | 500,00 mg · un flacon de 20 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.